Skip to Content
Merck
CN
  • Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.

Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.

eLife (2020-04-08)
Hee Won Yang, Steven D Cappell, Ariel Jaimovich, Chad Liu, Mingyu Chung, Leighton H Daigh, Lindsey R Pack, Yilin Fan, Sergi Regot, Markus Covert, Tobias Meyer
ABSTRACT

Mammalian cells typically start the cell-cycle entry program by activating cyclin-dependent protein kinase 4/6 (CDK4/6). CDK4/6 activity is clinically relevant as mutations, deletions, and amplifications that increase CDK4/6 activity contribute to the progression of many cancers. However, when CDK4/6 is activated relative to CDK2 remained incompletely understood. Here, we developed a reporter system to simultaneously monitor CDK4/6 and CDK2 activities in single cells and found that CDK4/6 activity increases rapidly before CDK2 activity gradually increases, and that CDK4/6 activity can be active after mitosis or inactive for variable time periods. Markedly, stress signals in G1 can rapidly inactivate CDK4/6 to return cells to quiescence but with reduced probability as cells approach S phase. Together, our study reveals a regulation of G1 length by temporary inactivation of CDK4/6 activity after mitosis, and a progressively increasing persistence in CDK4/6 activity that restricts cells from returning to quiescence as cells approach S phase.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Oligomycin A, ≥99% (HPLC)